Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2024

Pharma News, 2024

Dr Reddy’s, Aurigene and Kainomyx to co-develop anti-malarials
Dr Reddy’s, Aurigene and Kainomyx to co-develop anti-malarials
Dr Reddy’s Laboratories, alongside its division Aurigene Pharmaceutical Services, has entered into a non-binding memorandum of understanding (MoU) with US-based Kainomyx to co-develop and co...
Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials
Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials
Amneal Pharmaceuticals, Inc. today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for Propofol Injecta...
Type 2 diabetes increased by almost 20% over a decade
Type 2 diabetes increased by almost 20% over a decade
Type 2 diabetes increased by almost 20% between 2012 and 2022, according to a new study from the University of Georgia published in Diabetes, Obesity and Metabolism. The researchers found an incre...
New York Biotech Firm’s Anti-Bleed Gel for Soldiers Receives FDA Clearance
New York Biotech Firm’s Anti-Bleed Gel for Soldiers Receives FDA Clearance
Biotechnology firm Cresilon Inc. has received a US Food and Drug Administration (FDA) 510(k) clearance for its Traumagel external bleeding solution for warfighters. Traumagel is a plan...
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
Over the last couple of years, the pharmaceutical industry has been taken over by glucagon-like peptide-1 (GLP-1) agonists.  
XF platform to be tested against CF-related MRSA lung infection
XF platform to be tested against CF-related MRSA lung infection
Destiny Pharma is launching a research program to test a potential therapy derived from its XF drug platform for methicillin-resistant Staphylococcus aureus (MRSA) lung infections in people wi...
COVID-19 is on the upswing in the US
COVID-19 is on the upswing in the US
COVID-19 hasn't gone away, and data from the Centers for Disease Control and Prevention suggests it's on the upswing around the country.
Researchers develop new chemical method to enhance drug discovery
Researchers develop new chemical method to enhance drug discovery
Moffitt Cancer Center researchers have developed a novel reagent that enhances the precision of drug synthesis. This innovative method, published in Nature Communications, introduces a new sulfur ...
FDA accepts Deciphera’s vimseltinib NDA for priority review
FDA accepts Deciphera’s vimseltinib NDA for priority review
The US Food and Drug Administration (FDA) has accepted for priority review the new drug application (NDA) for Ono Pharmaceutical subsidiary Deciphera Pharmaceuticals’ vimseltinib, a ...
FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung Cancer
FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung Cancer
AstraZeneca AZN announced that the FDA expanded the label of its blockbuster cancer drug Imfinzi for a fourth indication in lung cancer.
World Health Organization Declares New Mpox Outbreak a Global Public Health Emergency
World Health Organization Declares New Mpox Outbreak a Global Public Health Emergency
The current outbreak has infected more than 14,000 people and spread to 13 different African countries.
Acelyrin deprioritises lead therapy despite Phase III win, fires 33% of staff
Acelyrin deprioritises lead therapy despite Phase III win, fires 33% of staff
As part of pipeline reprioritisation, Acelyrin has dropped izokibep and will instead start Phase III trials for lonigutamab in Q1 2025. Acelyrin has decided to shake up its pipeline; while the company...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand